Bacteriostatic water is an inexpensive generic pharmacy aid used to dilute or dissolve certain injectable medications, but the cash price can still vary a lot from one pharmacy to the next
Food and Drug Administration announced on April 30, 2026, that it is considering removing several popular GLP-1 medications from the agencys 503B bulks list a decision that could significantly reduce the supply of compounded versions of these drugs in the United States
This can happen because of a sudden drop in blood pressure or not having enough fluid in the body
While Phase II trials in heart failure and primary mitochondrial myopathy did not meet primary efficacy endpoints, the TAZPOWER trial in Barth syndrome demonstrated significant improvements in muscle strength and sixminute walk distance, leading to FDA accelerated approval in 2025 [3][10]
Moreover, these findings are clinically relevant as they clearly show that GLP-1R activation improves stroke recovery by acting on two independent mechanisms: induction of pre-stroke weight loss and acute neuroprotection post-stroke
